Skip to main content

Table 2 Analysis of cell surface marker expressions by flow cytometry after transfection (%, mean ± SD)

From: Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain

Groups (BMSCs)

Number

CD29

CD44

CD34

CD45

Control

4

99.04 ± 0.68

94.74 ± 1.74

0.35 ± 0.16

1.75 ± 0.46

miR-NC

4

98.46 ± 0.83

95.01 ± 2.42

0.41 ± 0.31

1.52 ± 0.41

miR-9 mimics

4

98.79 ± 1.06

93.68 ± 2.68

0.54 ± 0.35

1.69 ± 0.51

p value

0.214

0.124

0.367

0.395

  1. BMSCs among different groups were analyzed for CD 29, 34, 44, and 45 expressions using fluorescence-activated cell sorting (FACS) with flow cytometry at passage 3. The lack of CD 34 and 45 expressions and the presence of CD 29 and 44 expressions indicated a remaining mesenchymal stem cell lineage after miR-9 mimic transfection